Pentokey Organy (India) Ltd
Incorporated in 1986, Pentokey Organy (India) Ltd trades pharmaceutical products.[1]
- Market Cap ₹ 29.5 Cr.
- Current Price ₹ 47.0
- High / Low ₹ 64.0 / 27.5
- Stock P/E 42.7
- Book Value ₹ 15.1
- Dividend Yield 0.00 %
- ROCE 2.67 %
- ROE 2.67 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 99.1 to 128 days.
- Working capital days have increased from 601 days to 1,245 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123.58 | 121.70 | 85.44 | 0.76 | 4.70 | 9.29 | 1.56 | 0.00 | 0.00 | 4.37 | 4.39 | 0.83 | 5.89 | |
121.68 | 122.45 | 88.66 | 2.59 | 5.31 | 10.10 | 2.25 | 0.54 | 0.41 | 3.52 | 3.95 | 1.04 | 5.57 | |
Operating Profit | 1.90 | -0.75 | -3.22 | -1.83 | -0.61 | -0.81 | -0.69 | -0.54 | -0.41 | 0.85 | 0.44 | -0.21 | 0.32 |
OPM % | 1.54% | -0.62% | -3.77% | -240.79% | -12.98% | -8.72% | -44.23% | 19.45% | 10.02% | -25.30% | 5.43% | ||
0.30 | 0.40 | 0.25 | 14.79 | 0.98 | 1.17 | 0.25 | 0.30 | 0.25 | 2.36 | 0.45 | 0.46 | 0.37 | |
Interest | 3.53 | 3.46 | 3.70 | 2.19 | 0.26 | 0.05 | 0.00 | 0.00 | 0.00 | 0.03 | 0.01 | 0.00 | 0.00 |
Depreciation | 0.79 | 0.59 | 0.62 | 0.63 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | -2.12 | -4.40 | -7.29 | 10.14 | 0.05 | 0.31 | -0.44 | -0.24 | -0.16 | 3.18 | 0.88 | 0.25 | 0.69 |
Tax % | 0.00% | 0.00% | 22.50% | 5.23% | 80.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
-2.12 | -4.40 | -8.94 | 9.61 | 0.01 | 0.31 | -0.44 | -0.24 | -0.16 | 3.18 | 0.87 | 0.25 | 0.69 | |
EPS in Rs | -3.38 | -7.01 | -14.25 | 15.32 | 0.02 | 0.49 | -0.70 | -0.38 | -0.26 | 5.07 | 1.39 | 0.40 | 1.11 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | -39% |
5 Years: | -12% |
3 Years: | % |
TTM: | 180% |
Compounded Profit Growth | |
---|---|
10 Years: | 7% |
5 Years: | 21% |
3 Years: | 53% |
TTM: | 38% |
Stock Price CAGR | |
---|---|
10 Years: | 13% |
5 Years: | 55% |
3 Years: | 31% |
1 Year: | -21% |
Return on Equity | |
---|---|
10 Years: | -21% |
5 Years: | 11% |
3 Years: | 17% |
Last Year: | 3% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 | 6.27 |
Reserves | 3.23 | -1.25 | -10.18 | -0.57 | -0.55 | -0.23 | -0.68 | -0.91 | -1.07 | 2.11 | 2.99 | 3.18 |
24.77 | 27.28 | 17.99 | 6.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
17.02 | 18.03 | 6.99 | 3.65 | 0.47 | 0.88 | 0.49 | 0.15 | 0.05 | 0.54 | 0.24 | 0.34 | |
Total Liabilities | 51.29 | 50.33 | 21.07 | 15.85 | 6.19 | 6.92 | 6.08 | 5.51 | 5.25 | 8.92 | 9.50 | 9.79 |
9.93 | 9.41 | 10.36 | 0.12 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | |
CWIP | 0.09 | 0.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | 0.04 | 1.24 |
41.27 | 40.37 | 10.71 | 15.73 | 6.17 | 6.89 | 6.06 | 5.48 | 5.22 | 8.89 | 9.46 | 8.55 | |
Total Assets | 51.29 | 50.33 | 21.07 | 15.85 | 6.19 | 6.92 | 6.08 | 5.51 | 5.25 | 8.92 | 9.50 | 9.79 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1.62 | 0.08 | 12.43 | -2.99 | 8.31 | -1.95 | 0.86 | 0.56 | -0.42 | -0.10 | 0.55 | 0.22 | |
-0.11 | 0.49 | -0.19 | 15.92 | -0.61 | 1.70 | -0.89 | -0.55 | 0.23 | 0.19 | -0.59 | -0.20 | |
-1.07 | -0.70 | -12.42 | -13.16 | -7.29 | -0.01 | 0.00 | 0.00 | 0.00 | -0.03 | -0.01 | 0.00 | |
Net Cash Flow | 0.44 | -0.13 | -0.17 | -0.23 | 0.42 | -0.25 | -0.03 | 0.01 | -0.19 | 0.06 | -0.04 | 0.01 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 29.68 | 26.57 | 0.81 | 0.00 | 15.53 | 86.44 | 224.62 | 12.53 | 157.14 | 127.53 | ||
Inventory Days | 47.58 | 50.84 | 2.19 | 93.37 | 6.77 | 11.10 | 0.00 | 23.95 | 0.00 | 167.29 | ||
Days Payable | 48.09 | 54.11 | 16.31 | 492.33 | 22.87 | 26.95 | 45.62 | 65.90 | ||||
Cash Conversion Cycle | 29.17 | 23.30 | -13.31 | -398.95 | -0.56 | 70.58 | 224.62 | -9.14 | 157.14 | 228.92 | ||
Working Capital Days | -5.23 | 4.47 | -17.00 | 5,249.28 | 226.77 | 122.19 | 299.49 | 283.98 | 273.54 | 1,244.52 | ||
ROCE % | 4.08% | -2.82% | -15.83% | -16.44% | -5.47% | -10.37% | -7.57% | -4.38% | -3.03% | 47.28% | 10.09% | 2.67% |
Documents
Announcements
-
Appointment of Company Secretary and Compliance Officer
11 Aug - Appointed Saurabh Mishra as Company Secretary and Compliance Officer from 12 Aug 2025.
-
Result- Financial Result 30Th June, 2025
11 Aug - Auditor's review report confirms no material misstatement in Q1 June 2025 financial results.
-
Board Meeting Outcome for Approval Of Unaudited Financial Result For The Quarter Ended 30Th June, 2025
11 Aug - Auditor reviewed Q1 FY2025 financials; no material misstatements found, compliant with SEBI norms.
-
Board Meeting Intimation for Intimation Of The Board Meeting Scheduled To Be Held On Monday, 11Th August, 2025
5 Aug - Board meeting on 11 Aug 2025 to approve Q1 June 2025 unaudited financial results.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
24 Jul - Certificate received from Datamatics business solutions Ltd., the Registrar and Share transfer agent of the company for the quarter ended 30th June, 2025.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
POIL is in the business of trading pharmaceutical products.